Amerikanische Gesellschaft für Hirudotherapie

Leech-borne Serratia marcescens infection following complex hand injury.

Case report published in British journal of plastic surgery (1998)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportSicherheit & InfektionskontrollePereira et al. · British journal of plastic surgery, 1998

Abstract

Leeches are commonly used in the postoperative course of plastic surgical operations where there is venous congestion in a pedicled or free flap. They provide a temporary relief to venous engorgement whilst venous drainage is re-established. It is known that leeches can carry Aeromonas hydrophila infection, and a second or third generation cephalosporin antibiotic has traditionally been given as prophylaxis against infection. We report a new observation that leeches can carry Serratia marcescens and give rise to clinically significant infection. The implication for prophylaxis and treatment of leech-associated cellulitis is discussed.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article
Indexed MeSH termsAdultAnimalsFemaleFinger InjuriesHumansLeechesPhlebotomyReplantationSerratia InfectionsSerratia marcescens

Zusammenfassung

Leeches are commonly used in the postoperative course of plastic surgical operations where there is venous congestion in a pedicled or free flap. They provide a temporary relief to venous engorgement whilst venous drainage is re-established.

Warum dies für die Hirudotherapie relevant ist

This case report documents a new observation that medicinal leeches can carry Serratia marcescens and give rise to clinically significant infection. The abstract describes leeches as commonly used in plastic surgical operations where there is venous congestion in a pedicled or free flap, notes that Aeromonas hydrophila is the traditionally recognized leech-associated pathogen with second- or third-generation cephalosporin prophylaxis as standard, and discusses implications for prophylaxis and treatment of leech-associated cellulitis. This article is directly relevant to ASH's domain as it concerns a safety issue in clinical leech use—bacterial transmission risk—and challenges existing prophylaxis assumptions. However, it is a case report, so its findings about Serratia as a leech-borne pathogen are limited in scope and cannot establish prevalence or comprehensive recommendations.

Zitation

Leech-borne Serratia marcescens infection following complex hand injury.

Pereira et al. · British journal of plastic surgery, 1998

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 28, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.